| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Traws Pharma, Inc. | Director | Common Stock | 6.17K | $15.8K | $2.56 | 12 Dec 2025 | Direct |
| NorthView Acquisition Corp | Chief Executive Officer, Director, 10%+ Owner | Private Warrants to purchase common stock | 5.16M | 20 Dec 2021 | By NorthView Sponsor I, LLC | ||
| NorthView Acquisition Corp | Chief Executive Officer, Director, 10%+ Owner | Common Stock | 4.74M | 20 Dec 2021 | By NorthView Sponsor I, LLC | ||
| Traws Pharma, Inc. | Director | Stock Option (right to purchase) | 24.6K | 12 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RNAZ | Transcode Therapeutics, Inc. | 19 Dec 2025 | 0 | $0 | 3 | Director | 22 Dec 2025, 16:39 |
| TRAW | Traws Pharma, Inc. | 12 Dec 2025 | 2 | $0 | 4 | Director | 16 Dec 2025, 18:20 |
| TRAW | Traws Pharma, Inc. | 12 Oct 2025 | 1 | $0 | 4 | Director | 15 Oct 2025, 20:05 |
| TRAW | Traws Pharma, Inc. | 19 Jun 2025 | 1 | $0 | 4 | Director | 23 Jun 2025, 17:54 |
| ONTX | Onconova Therapeutics, Inc. | 10 Aug 2023 | 1 | $0 | 4 | Director | 14 Aug 2023, 17:52 |
| ONTX | Onconova Therapeutics, Inc. | 18 Aug 2022 | 1 | $0 | 4 | Director | 19 Aug 2022, 17:10 |
| PMCB | PharmaCyte Biotech, Inc. | 15 Aug 2022 | 0 | $0 | 3 | Director | 23 Aug 2022, 21:22 |
| NVAC | NorthView Acquisition Corp | 20 Dec 2021 | 1 | $5.16M | 4 | Chief Executive Officer, Director, 10%+ Owner | 23 Dec 2021, 16:27 |
| NVAC | NorthView Acquisition Corp | 20 Dec 2021 | 0 | $0 | 3 | Chief Executive Officer, Director, 10%+ Owner | 23 Dec 2021, 16:27 |
| ONTX | Onconova Therapeutics, Inc. | 30 Jul 2021 | 1 | $0 | 4 | Director | 30 Jul 2021, 19:21 |